Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir

Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, Ariana T. Leonelli, View ORCID ProfileBrittany A. Petros, Taylor Brock-Fisher, Sabrina T. Dobbins, Bronwyn L. MacInnis, Amelia Capone, Nancy Littlehale, Julie Boucau, Caitlin Marino, Amy K. Barczak, Pardis C. Sabeti, View ORCID ProfileMichael Springer, View ORCID ProfileKathryn E. Stephenson
doi: https://doi.org/10.1101/2022.08.04.22278378
Eric Y. Dai
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kannon A. Lee
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey B. Nathanson
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ariana T. Leonelli
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany A. Petros
2Department of Systems Biology, Harvard Medical School, Boston, MA, USA
3Harvard-MIT MD/PhD Program, Boston, MA, USA
4Harvard-MIT Program in Health Sciences and Technology, Cambridge, MA
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brittany A. Petros
Taylor Brock-Fisher
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabrina T. Dobbins
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bronwyn L. MacInnis
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
6Harvard T.H. Chan School of Public Health, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amelia Capone
7Beth Israel Lahey Health Primary Care, Chelsea, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nancy Littlehale
7Beth Israel Lahey Health Primary Care, Chelsea, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Boucau
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Caitlin Marino
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy K. Barczak
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
9Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, USA
10Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pardis C. Sabeti
5Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
6Harvard T.H. Chan School of Public Health, Boston, MA, USA
11Department of Organismic and Evolutionary Biology, Harvard University, Cambridge, MA, USA
12Howard Hughes Medical Institute, Chevy Chase, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Springer
2Department of Systems Biology, Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Springer
  • For correspondence: Michael_springer{at}hms.harvard.edu
Kathryn E. Stephenson
1Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA
8Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA
10Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn E. Stephenson
  • For correspondence: kstephen{at}bidmc.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

We measured viral kinetics of SARS-CoV-2 Omicron infection in 36 mRNA-vaccinated individuals, 11 of whom were treated with nirmatrelvir-ritonavir (NMV-r). We found that NMV-r was associated with greater incidence of viral rebound compared to no treatment. For those that did not rebound, NMV-r significantly reduced time to PCR conversion.

Competing Interest Statement

P.C.S. is a co-founder of, shareholder in, and scientific advisor to Sherlock Biosciences, Inc; she is also a Board member of and shareholder in Danaher Corporation. P.C.S. has filed IP related to genome sequencing and analysis. The authors declare no other conflicts of interests.

Funding Statement

This study was supported by the Massachusetts Consortium for Pathogen Readiness (K.E.S. and A.K.B.), Beth Israel Deaconess Medical Center (K.E.S.), National Institutes of Health (R01-GM120122 to M.S.),Harvard Catalyst, the National Institute of General Medical Sciences (T32GM007753 to B.A.P.), the Centers for Disease Control and Prevention (CDC) COVID-19 baseline genomic surveillance contract to the Clinical Research Sequencing Platform (75D30121C10501 to B.L.M.), a CDC Broad Agency Announcement (75D30120C09605 to B.L.M.), the National Institute of Allergy and Infectious Diseases (U19AI110818 and U01AI151812 to P.C.S.), and Howard Hughes Medical Institute (P.C.S.). The BSL3 laboratory where viral culture work was performed is supported by the Harvard Center for AIDS Research (CFAR) (US National Institutes of Health P30 AI060354).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Committee on Clinical Investigations/Institutional Review Board of Beth Israel Deaconess Medical Center gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2022.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, Ariana T. Leonelli, Brittany A. Petros, Taylor Brock-Fisher, Sabrina T. Dobbins, Bronwyn L. MacInnis, Amelia Capone, Nancy Littlehale, Julie Boucau, Caitlin Marino, Amy K. Barczak, Pardis C. Sabeti, Michael Springer, Kathryn E. Stephenson
medRxiv 2022.08.04.22278378; doi: https://doi.org/10.1101/2022.08.04.22278378
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Viral Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in mRNA-Vaccinated Individuals Treated and Not Treated with Nirmatrelvir-Ritonavir
Eric Y. Dai, Kannon A. Lee, Audrey B. Nathanson, Ariana T. Leonelli, Brittany A. Petros, Taylor Brock-Fisher, Sabrina T. Dobbins, Bronwyn L. MacInnis, Amelia Capone, Nancy Littlehale, Julie Boucau, Caitlin Marino, Amy K. Barczak, Pardis C. Sabeti, Michael Springer, Kathryn E. Stephenson
medRxiv 2022.08.04.22278378; doi: https://doi.org/10.1101/2022.08.04.22278378

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)